Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-10

Clinical Trial Update: An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT) [NA]

View source ↗

Summary

A completed clinical trial evaluating a novel glucose sensing technology for reducing hypoglycemia in Type 1 diabetes, sponsored by Abbott Diabetes Care; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Investigational glucose sensing technology (IMPACT)

Snippet

Sponsor: Abbott Diabetes Care | Conditions: Type 1 Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2017-04-10